The past decade has witnessed the explosive development of cancer immunotherapies.
Nevertheless, low immunogenicity, limited specificity, poor delivery efficiency, and off‐target …

Cancer immunotherapy, as a paradigm shift in cancer treatment, has recently received
tremendous attention. The active cancer vaccination, immune checkpoint blockage (ICB) …

Immunotherapy involves the therapeutic alteration of the patient's immune system to identify,
target, and eliminate cancer cells. Dendritic cells, macrophages, myeloid-derived …

Highlights•Biomaterials can potentially improve the safety and efficacy of cancer
immunotherapy.•Biomaterials scaffolds can program immune cell function in peripheral …

Cancer immunotherapy has recently shown dramatic clinical success inducing durable
response in patients of a wide variety of malignancies. Further improvement of the clinical …

The past decade has witnessed the accelerating development of immunotherapies for
cancer treatment. Immune checkpoint blockade therapies and chimeric antigen receptor …

Cancer immunotherapies have revolutionized the treatment of numerous cancers, with
exciting results often superior to conventional treatments, such as surgery and …

Cancer immunotherapy has become an emerging strategy recently producing durable
immune responses in patients with varieties of malignant tumors. However, the main …

Immunotherapies for cancer have progressed enormously over the past few decades, and
hold great promise for the future. The successes of these therapies, with some patients …

The discovery of immune checkpoint blockade has revolutionized the field of immuno‐
oncology and established the foundation for developing various new therapies that can …